eQlsoPkejraNdg
Withdraw cash average cost of staxyn In that context, “it is disappointing to see that the drug had failed its first of three phase III trial read-outs for the treatment of melanoma”, he added. The analyst views the failure “as a missed upgrading opportunity but it is unlikely, in our view, to trigger downgrades”.